HIV-1

"HIV-1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte.

Descriptor ID	D015497
MeSH Number(s)	B04.820.650.589.650.350.400
Concept/Terms	HIV-1 HIV-1 Human immunodeficiency virus 1 HIV-I Immunodeficiency Virus Type 1, Human Human Immunodeficiency Virus Type 1

Below are MeSH descriptors whose meaning is more general than "HIV-1".

Organisms [B]
Viruses [B04]
RNA Viruses [B04.820]
Retroviridae [B04.820.650]
Lentivirus [B04.820.650.589]
Lentiviruses, Primate [B04.820.650.589.650]
HIV [B04.820.650.589.650.350]
HIV-1 [B04.820.650.589.650.350.400]

Below are MeSH descriptors whose meaning is related to "HIV-1".

Below are MeSH descriptors whose meaning is more specific than "HIV-1".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "HIV-1" by people in this website by year, and whether "HIV-1" was a major or minor topic of these publications.

Bar chart showing 521 publications over 31 distinct years, with a maximum of 31 publications in 2008

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1993	11	0	11
1994	9	1	10
1995	10	0	10
1996	19	1	20
1997	10	1	11
1998	7	1	8
1999	6	3	9
2000	12	2	14
2001	7	0	7
2002	10	3	13
2003	21	3	24
2004	10	5	15
2005	22	0	22
2006	17	2	19
2007	13	3	16
2008	24	7	31
2009	21	3	24
2010	22	6	28
2011	21	7	28
2012	27	3	30
2013	22	0	22
2014	21	5	26
2015	18	0	18
2016	15	7	22
2017	6	3	9
2018	21	6	27
2019	10	5	15
2020	11	4	15
2021	3	3	6
2022	4	1	5
2023	6	0	6

Below are the most recent publications written about "HIV-1" by people in Profiles.

Wang Y, Lifshitz L, Silverstein NJ, Mintzer E, Luk K, StLouis P, Brehm MA, Wolfe SA, Deeks SG, Luban J. Transcriptional and chromatin profiling of human blood innate lymphoid cell subsets sheds light on HIV-1 pathogenesis. EMBO J. 2023 08 15; 42(16):e114153.

View in: PubMed
Xue G, Yu HJ, Buffone C, Huang SW, Lee K, Goh SL, Gres AT, Guney MH, Sarafianos SG, Luban J, Diaz-Griffero F, KewalRamani VN. The HIV-1 capsid core is an opportunistic nuclear import receptor. Nat Commun. 2023 Jun 24; 14(1):3782.

View in: PubMed
Lockbaum GJ, Rusere LN, Henes M, Kosovrasti K, Rao DN, Spielvogel E, Lee SK, Nalivaika EA, Swanstrom R, Yilmaz NK, Schiffer CA, Ali A. HIV-1 protease inhibitors with a P1 phosphonate modification maintain potency against drug-resistant variants by increased interactions with flap residues. Eur J Med Chem. 2023 Sep 05; 257:115501.

View in: PubMed
Spielvogel E, Lee SK, Zhou S, Lockbaum GJ, Henes M, Sondgeroth A, Kosovrasti K, Nalivaika EA, Ali A, Yilmaz NK, Schiffer CA, Swanstrom R. Selection of HIV-1 for resistance to fifth-generation protease inhibitors reveals two independent pathways to high-level resistance. Elife. 2023 03 15; 12.

View in: PubMed
Abeynaike SA, Huynh TR, Mehmood A, Kim T, Frank K, Gao K, Zalfa C, Gandarilla A, Shultz L, Paust S. Human Hematopoietic Stem Cell Engrafted IL-15 Transgenic NSG Mice Support Robust NK Cell Responses and Sustained HIV-1 Infection. Viruses. 2023 01 27; 15(2).

View in: PubMed
Olety B, Usami Y, Wu Y, Peters P, G?ttlinger H. AP-2 Adaptor Complex-Dependent Enhancement of HIV-1 Replication by Nef in the Absence of the Nef/AP-2 Targets SERINC5 and CD4. mBio. 2023 02 28; 14(1):e0338222.

View in: PubMed
Wedrychowski A, Martin HA, Li Y, Telwatte S, Kadiyala GN, Melberg M, Etemad B, Connick E, Jacobson JM, Margolis DM, Skiest D, Volberding P, Hecht F, Deeks S, Wong JK, Li JZ, Yukl SA. Transcriptomic Signatures of Human Immunodeficiency Virus Post-Treatment Control. J Virol. 2023 01 31; 97(1):e0125422.

View in: PubMed
Samant N, Nachum G, Tsepal T, Bolon DNA. Sequence dependencies and biophysical features both govern cleavage of diverse cut-sites by HIV protease. Protein Sci. 2022 07; 31(7):e4366.

View in: PubMed
Myint W, Schiffer CA, Matsuo H. HIV-1 VIF and human APOBEC3G interaction directly observed through molecular specific labeling using a new dual promotor vector. J Magn Reson. 2022 06; 339:107230.

View in: PubMed
Delany-Moretlwe S, Hughes JP, Bock P, Ouma SG, Hunidzarira P, Kalonji D, Kayange N, Makhema J, Mandima P, Mathew C, Spooner E, Mpendo J, Mukwekwerere P, Mgodi N, Ntege PN, Nair G, Nakabiito C, Nuwagaba-Biribonwoha H, Panchia R, Singh N, Siziba B, Farrior J, Rose S, Anderson PL, Eshleman SH, Marzinke MA, Hendrix CW, Beigel-Orme S, Hosek S, Tolley E, Sista N, Adeyeye A, Rooney JF, Rinehart A, Spreen WR, Smith K, Hanscom B, Cohen MS, Hosseinipour MC. Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial. Lancet. 2022 05 07; 399(10337):1779-1789.

View in: PubMed

People

Explore

Similar Concepts

Top Journals